0001628908-22-000009.txt : 20220207 0001628908-22-000009.hdr.sgml : 20220207 20220207170555 ACCESSION NUMBER: 0001628908-22-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220203 FILED AS OF DATE: 20220207 DATE AS OF CHANGE: 20220207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tutewohl Steve CENTRAL INDEX KEY: 0001811845 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37415 FILM NUMBER: 22598387 MAIL ADDRESS: STREET 1: 800 NORTH GLEBE ROAD STREET 2: SUITE 500 CITY: ARLINGTON STATE: VA ZIP: 22203 FORMER NAME: FORMER CONFORMED NAME: Tutewohi Steve DATE OF NAME CHANGE: 20200512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evolent Health, Inc. CENTRAL INDEX KEY: 0001628908 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741] IRS NUMBER: 320454912 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 NORTH GLEBE RD, SUITE 500 CITY: ARLINGTON STATE: VA ZIP: 22203 BUSINESS PHONE: 571-389-6000 MAIL ADDRESS: STREET 1: 800 NORTH GLEBE RD, SUITE 500 CITY: ARLINGTON STATE: VA ZIP: 22203 4 1 wf-form4_164427153879648.xml FORM 4 X0306 4 2022-02-03 0 0001628908 Evolent Health, Inc. EVH 0001811845 Tutewohl Steve C/O EVOLENT HEALTH, INC. 800 NORTH GLEBE ROAD, SUITE 500 ARLINGTON VA 22203 0 1 0 0 Chief Operating Officer Class A Common Stock 2022-02-03 4 S 0 1707 22.85 D 98843 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.39 to $23.61, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. /s/ Jonathan Weinberg, Attorney-in-fact 2022-02-07